Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
NAMSW:NASDAQ
NewAmsterdam Pharma Co
$22.21
0.00%
(0.00) 1D
Apr 21, 9:46:06 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAMSW...
Mkt. cap
3.62B
Avg. vol.
1.65K
Volume
0.00
52-wk high
$29.99
52-wk low
$7.16
Beta
6.89
No. of employees
100
News stories
From sources across the web
About NewAmsterdam Pharma Co
CEO-
Employees100
Founded2019
Headquarters-
SectorBiotechnology
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.98M
19.14M
348.00K
32.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
44.75M
27.52M
30.97M
38.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.15M
27.26M
24.52M
27.42M
Operating expense
71.90M
54.78M
55.49M
66.01M
Total operating expenses
71.90M
54.78M
55.49M
66.01M
Operating income
-68.92M
-35.64M
-55.14M
-65.98M
Other non operating income
13.76M
2.59M
-23.79M
-15.34M
EBT including unusual items
-39.53M
-17.36M
-72.00M
-74.92M
EBT excluding unusual items
-43.52M
-17.36M
-72.00M
-74.92M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39.53M
-17.36M
-72.00M
-74.92M
Net profit margin
-1,327.30%
-90.70%
-20,691.09%
-234,134.38%
Earnings per share
-
-
-
-
Interest and investment income
7.35M
7.06M
6.71M
6.47M
Interest expense
-
-
-
-
Net interest expenses
7.35M
7.06M
6.71M
6.47M
Depreciation and amortization charges
-
-
-
-
EBITDA
-68.87M
-35.59M
-55.08M
-65.92M
Gain or loss from assets sale
-
-
1.00K
11.00K
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more